Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Explore the retirement accounts that yield the highest returns. Make informed decisions to grow your retirement savings effectively.
25,325 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A clear, practical guide to interpreting the CWK 2026 earnings transcript. Learn what matters, how to quantify signal...
A timely analysis of pff’s billion preferred stock exposure reveals how call provisions and a bank-heavy portfolio co...
Three quantum hardware players—IonQ, D-Wave, and Rigetti—are confronting a tough market reality. This article breaks ...
Broadcom is pursuing a bold AI compute strategy that could reshape its growth trajectory. This article breaks down th...
Salesforce leans on a sweeping buyback to defend its core, while ServiceNow expands through acquisitions focused on s...
A major institution disclosed a new roughly $5 million stake in Central Bancompany, helping fuel a 20% gain since its...
One mega-cap could re-enter the elite $4 trillion club, powered by AI, cloud momentum, and strong cash flow. This pie...
Rivian unveils the R2 with a sub-$45k price target and near-term shipments, while Lucid battles cash burn and no 2026...
Dell Technologies slid sharply on a broader AI rotation, yet fundamentals remained solid, prompting Jim Cramer to cal...
This guide decodes MKSI's 2026 earnings call, explaining what to watch, how management guidance shapes strategy, and ...
Shoe Carnival's 2025 earnings season offers clues about margins, online growth, and store results. This guide breaks ...